Impact of Urate-Lowering Therapy on the Risk of Cardiovascular Events and All-Cause Mortality Among Individuals with Gout

被引：0
|
作者：
Choi, In Ah [1 ]
Jang, Hoyeon [2 ]
Kang, Gil-Won [2 ]
机构：
[1] Chungbuk Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Cheongju, South Korea
[2] Chungbuk Natl Univ, Coll Med, Dept Hlth Informat & Management, Cheongju, South Korea
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1128
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes
    Zhang, W. L.
    Lopez-Garcia, E.
    Li, T. Y.
    Hu, F. B.
    van Dam, R. M.
    DIABETOLOGIA, 2009, 52 (05) : 810 - 817
  • [42] Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes
    W. L. Zhang
    E. Lopez-Garcia
    T. Y. Li
    F. B. Hu
    R. M. van Dam
    Diabetologia, 2009, 52 : 810 - 817
  • [43] Associations of Dietary Magnesium Intake with All-Cause and Cause-Specific Mortality Among Individuals with Gout and Hyperuricemia
    Lu, Xuanni
    Wang, Anqi
    Liu, Ke
    Chen, Ying
    Chen, Weiwei
    Mao, Yingying
    Ye, Ding
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2024,
  • [44] Bicycling and all-cause mortality among individuals with diabetes
    Ried-Larsen, M.
    Rasmussen, M. G.
    Blond, K.
    Andersen, L. B.
    Wareham, N.
    Brage, S.
    Grontved, A.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S98 - S98
  • [45] Association of gout with major adverse cardiovascular events and all-cause mortality in patients with peripheral artery disease
    Singh, Tejas P.
    Wong, Shannon
    Quigley, Frank
    Jenkins, Jason
    Golledge, Jonathan
    ATHEROSCLEROSIS, 2020, 312 : 23 - 27
  • [46] Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis
    Yin, Rulan
    Li, Lin
    Zhang, Guo
    Cui, Yafei
    Zhang, Lijuan
    Zhang, Qiuxiang
    Fu, Ting
    Cao, Haixia
    Li, Liren
    Gu, Zhifeng
    BMJ OPEN, 2018, 8 (04):
  • [47] Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients
    Chung T.-T.
    Yu K.-H.
    Kuo C.-F.
    Luo S.-F.
    Chiou M.-J.
    Lan W.-C.
    Chen J.-S.
    Tseng W.-Y.
    Hsieh A.-H.
    Wang L.-C.
    Arthritis Research & Therapy, 21 (1)
  • [48] BUDGETARY IMPACT OF A NEW URATE-LOWERING THERAPY (ULT) FOR THE TREATMENT OF GOUT IN A US HEALTH PLAN FORMULARY
    Pandya, B. J.
    Quimbo, R. A.
    Mody, R.
    Srikanth, S.
    Dabbous, O.
    VALUE IN HEALTH, 2009, 12 (07) : A435 - A435
  • [49] Atrial Fibrillation Risk and Urate-Lowering Therapy in Patients with Gout: A Cohort Study Using a Clinical Database
    Liu, Ching-Han
    Huang, Shih-Chung
    Yin, Chun-Hao
    Huang, Wei-Chun
    Chen, Jin-Shuen
    Chen, Yao-Shen
    Gan, Su-Ting
    Tzou, Shiow-Jyu
    Hsu, Ching-Tsai
    Wu, Hao-Ming
    Wang, Wen-Hwa
    BIOMEDICINES, 2023, 11 (01)
  • [50] Association of kidney disease index with all-cause and cardiovascular mortality among individuals with hypertension
    Fang, Suxia
    Chen, Yuwen
    Gao, Qiyue
    Wei, Qucheng
    CLINICAL CARDIOLOGY, 2023, 46 (11) : 1442 - 1449
12345